Launxp Biomedical Co (ROCO:6876) Days Payable: 0.00 (As of Dec. 2025)


ROCO:6876 Launxp Biomedical Co Ltd ROCO:6876
11 GF Score
Price NT$16.30
! 4 Warning Signs
View Full Analysis

What is Launxp Biomedical Co Days Payable?

Launxp Biomedical Co ROCO:6876 +0.62% 11 Days Payable is 0.00 as of Dec. 2025. GuruFocus rates ROCO:6876 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 699 Biotechnology companies, Launxp Biomedical Co ranks worse than 143061.37% on this metric.

Launxp Biomedical Co's average Accounts Payable for the six months ended in Dec. 2025 was NT$0.94 Mil. Launxp Biomedical Co's Cost of Goods Sold for the six months ended in Dec. 2025 was NT$0.00 Mil.

The historical rank and industry rank for Launxp Biomedical Co's Days Payable or its related term are showing as below:

During the past 6 years, Launxp Biomedical Co's highest Days Payable was 3968.23. The lowest was 3.46. And the median was 1985.85.

ROCO:6876's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Launxp Biomedical Co's Days Payable stayed the same from Dec. 2024 (0.00) to Dec. 2025 (0.00).

Launxp Biomedical Co Days Payable Historical Data

* Premium members only.

The historical data trend for Launxp Biomedical Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Launxp Biomedical Co Days Payable Chart

Launxp Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 0.00 0.00 0.00 3,968.23 0.00

Launxp Biomedical Co Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 1,909.37 0.00 0.00 0.00

ROCO:6876 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Launxp Biomedical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Launxp Biomedical Co Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Launxp Biomedical Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Launxp Biomedical Co's Days Payable falls into.


ROCO:6876
11GF Score
Launxp Biomedical Co Ltd ROCO:6876
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Launxp Biomedical Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Launxp Biomedical Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (2.384 + 0) / 1 ) / 0*365
=2.384 / 0*365
=N/A

Launxp Biomedical Co's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jun. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (0.943 + 0) / 1 ) / 0*365 / 2
=0.943 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Launxp Biomedical Co (ROCO:6876) has a Days Payable of 0.00 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Launxp Biomedical Co and its competitors. Over the past decade, Launxp Biomedical Co's Days Payable has ranged from 3.46 to 3,968.23. According to the industry distribution chart, Launxp Biomedical Co ranks #999999 out of 699 companies in the Biotechnology industry.
Is Launxp Biomedical Co's Days Payable too high?
Launxp Biomedical Co's current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 3.46 to a high of 3,968.23. Based on the distribution chart, Launxp Biomedical Co ranks #999999 out of 699 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Launxp Biomedical Co has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Launxp Biomedical Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Launxp Biomedical Co ranks #999999 out of 699 companies for Days Payable. This places Launxp Biomedical Co in the lower half of its industry. The industry median Days Payable is 112.84. Historically, Launxp Biomedical Co's own Days Payable has ranged from 3.46 to 3,968.23 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Launxp Biomedical Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Launxp Biomedical Co's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Launxp Biomedical Co stock overvalued right now?
Launxp Biomedical Co (ROCO:6876) has a current Days Payable of 0.00. The current Days Payable is 0.00. Launxp Biomedical Co's overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Launxp Biomedical Co (ROCO:6876), the current Days Payable is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Launxp Biomedical Co Business Description

Address 10F, No. 51, Section 2, Gongyi Road, Nantun District, Taichung, TWN, 408
Launxp Biomedical Co Ltd is a company that researches, designs and develops Cancer drug rapid screening platform and Early development evaluation and technology licensing of generic drugs for cancer treatment. The company mainly focuses on the screening of development drugs, formulation of development strategies, project management, planning and execution of regulations and clinical trials, etc.
11GF Score

Get the complete analysis for ROCO:6876

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.30
Price